SCHEMBL6001833

SCHEMBL6001833

O=C(O)c1[nH]c2ccc(I)cc2c1I

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 1/20 0.50
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HPGD P15428 2/20 0.42
POLB P06746 2/20 0.42
PKM P14618 1/20 0.42
NPY1R P25929 1/20 0.42
NPY2R P49146 1/20 0.42
HTT P42858 1/20 0.42
GFER P55789 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PRNP P04156 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PPARG P37231 1/20 0.42
HIF1A Q16665 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12597633 0.83 ALDH1A1 (0.61) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL1999382 0.83 MAP2 (0.61) GPR17KDM4EALDH1A1MEN1KMT2A
SCHEMBL3426959 0.83 MAP2 (0.51) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL27385781 0.80 GABRA1 (0.44) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL28095440 0.79 KDM4E (0.61) GPR17KDM4EALDH1A1MEN1KMT2A
SCHEMBL14300889 0.79 PPARG (0.50) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL12894776 0.79 EIF4A3 (0.57) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL31245675 0.78 KDM4E (0.61) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL2724876 0.78 KDM4E (0.61) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL2351650 0.77 GABRA1 (0.60) KDM4EALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128783-A1 Tyrosine kinase inhibitors DINSMORE CHRISTOPHER J 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128783-A1 Tyrosine kinase inhibitors ABL1, ERBB2, JAK2 GPR17 902/4885KDM4E 1265/4885ALDH1A1 2298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.